Highlights the risk of catatonic stupor and rapid clinical deterioration following the initiation of neuroleptic drug therapy.
No takes yet. Share an insight, caveat, or question.
Daniel R. Weinberger (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: